FEATURED COMPANIES
- Accenture
- BioClinica Inc.
- Cognizant
- IBM Corporation
- IQVIA
- Linical Accelovance
Global Pharmacovigilance Market to Reach $11.8 Billion by 2027
Amid the COVID-19 crisis, the global market for Pharmacovigilance estimated at US$5.4 Billion in the year 2020, is projected to reach a revised size of US$11.8 Billion by 2027, growing at a CAGR of 11.9% over the period 2020-2027. Contract Outsourcing, one of the segments analyzed in the report, is projected to record 13.1% CAGR and reach US$7.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the In-House segment is readjusted to a revised 10% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 15.7% CAGR
The Pharmacovigilance market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2027 trailing a CAGR of 15.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 10.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.4% CAGR.
Select Competitors (Total 42 Featured):
Amid the COVID-19 crisis, the global market for Pharmacovigilance estimated at US$5.4 Billion in the year 2020, is projected to reach a revised size of US$11.8 Billion by 2027, growing at a CAGR of 11.9% over the period 2020-2027. Contract Outsourcing, one of the segments analyzed in the report, is projected to record 13.1% CAGR and reach US$7.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the In-House segment is readjusted to a revised 10% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 15.7% CAGR
The Pharmacovigilance market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2027 trailing a CAGR of 15.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 10.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.4% CAGR.
Select Competitors (Total 42 Featured):
- Accenture
- ArisGlobal
- BioClinica Inc.
- Capgemini
- Cognizant
- FMD K&L
- IBM Corporation
- ICON Plc
- IQVIA
- ITClinical
- Laboratory Corporation of America Holdings
- Linical Accelovance
- Parexel International Corporation
- TAKE Solutions Ltd.
- United BioSource Corporation
- Wipro Ltd.
Frequently Asked Questions about the Global Market for Pharmacovigilance
What is the estimated value of the Global Market for Pharmacovigilance?
What is the growth rate of the Global Market for Pharmacovigilance?
What is the forecasted size of the Global Market for Pharmacovigilance?
Who are the key companies in the Global Market for Pharmacovigilance?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Accenture
- BioClinica Inc.
- Cognizant
- IBM Corporation
- IQVIA
- Linical Accelovance
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVE
1. MARKET OVERVIEW
III. MARKET ANALYSIS
IV. COMPETITION
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Accenture
- ArisGlobal
- BioClinica Inc.
- Capgemini
- Cognizant
- FMD K&L
- IBM Corporation
- ICON Plc
- IQVIA
- ITClinical
- Laboratory Corporation of America Holdings
- Linical Accelovance
- Parexel International Corporation
- TAKE Solutions Ltd.
- United BioSource Corporation
- Wipro Ltd.
Note: Product cover images may vary from those shown